GH Research PLC ( GHRS) - Key Metrics
GHRS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.23 | -$0.23 | -$0.23 |
| 2026Q1 | $0 | -$0.31 | -$0.17 | -$0.17 |
| 2025Q4 | $0 | -$0.23 | -$0.20 | -$0.20 |
| 2025Q3 | $0 | -$0.23 | -$0.23 | -$0.23 |
| 2025Q2 | $0 | -$0.15 | -$0.14 | -$0.15 |
GHRS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -29.22 |
| 2026Q1 | 0% | -11.34 |
| 2025Q4 | 0% | -13.80 |
| 2025Q3 | 0% | -15.54 |
| 2025Q2 | 0% | -20.32 |
GHRS
Price: $29.49
52 week price:
Earnings Per Share: -1.03 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Ireland
Volume: 6316
Market Capitalization: 2.1 billion